← Leaderboards
Maria Carlo
Sloan-Kettering Inst Can Research
$792,330
Attributed
$792,330
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $266.7K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$792,330 · 1
By mechanism
K08$792,330 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Kojo Seys Elenitoba-Johnson$15,478,914
- James A Fagin$27,970,638
- Xuejun Jiang$14,685,146
- Megan S. Lim$4,964,836
- William Robert Jarnagin$4,049,789
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectAggressive Clinical CourseAllelesAntioxidantsAppointmentAwardBioinformaticsBiological ModelsCancer ModelCancer-Predisposing GeneCancer PredispositionCancer PreventionCancer TherapyCareer DevelopmentCell GrowthCell LineClear Cell Renal Cell CarcinomaCohortCollaborationsCore FacilityCysteineDevelopment PlansDrug TargetingAdvisory Committees
Grant awards (3)
Investigating the Role of KEAP1 Germline and Somatic Mutations in Renal Cell Carcinoma$266,666
K08 · FY2025 · CA · contact PI
Investigating the Role of KEAP1 Germline and Somatic Mutations in Renal Cell Carcinoma$266,666
K08 · FY2024 · CA · contact PI
Investigating the Role of KEAP1 Germline and Somatic Mutations in Renal Cell Carcinoma$258,998
K08 · FY2023 · CA · contact PI